Search Results

There are 21443 results for: content related to: Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease

  1. Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers

    Acta Neurologica Scandinavica

    Volume 127, Issue 2, February 2013, Pages: 124–132, D. Nyholm, M. Ehrnebo, T. Lewander, C. G. Trolin, T. Bäckström, G. Panagiotidis, J. Spira, C. Nyström and S.-M. Aquilonius

    Version of Record online : 4 JUL 2012, DOI: 10.1111/j.1600-0404.2012.01700.x

  2. Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial

    European Journal of Neurology

    Volume 19, Issue 6, June 2012, Pages: 820–826, D. Nyholm, A. Johansson, H. Lennernäs and H. Askmark

    Version of Record online : 5 DEC 2011, DOI: 10.1111/j.1468-1331.2011.03614.x

  3. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  4. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Version of Record online : 21 OCT 2011, DOI: 10.1002/mds.23829

  5. Novel formulations and modes of delivery of levodopa

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 114–120, Werner Poewe and Angelo Antonini

    Version of Record online : 5 DEC 2014, DOI: 10.1002/mds.26078

  6. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  7. Inhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levels

    Movement Disorders

    Volume 21, Issue 3, March 2006, Pages: 332–336, Thomas Müller, Christoph Erdmann, Siegfried Muhlack, Dirk Bremen, Horst Przuntek and Dirk Woitalla

    Version of Record online : 6 OCT 2005, DOI: 10.1002/mds.20717

  8. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study

    Annals of Neurology

    Volume 68, Issue 1, July 2010, Pages: 18–27, Fabrizio Stocchi, Olivier Rascol, Karl Kieburtz, Werner Poewe, Joseph Jankovic, Eduardo Tolosa, Paulo Barone, Anthony E. Lang and C. Warren Olanow

    Version of Record online : 23 APR 2010, DOI: 10.1002/ana.22060

    Corrected by:

    Erratum: Erratum: Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study

    Vol. 68, Issue 3, 412–413, Version of Record online: 31 AUG 2010

  9. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  10. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  11. Lack of Pharmacokinetic Interactions Between Transdermal Rotigotine and Oral Levodopa/Carbidopa

    The Journal of Clinical Pharmacology

    Volume 49, Issue 9, September 2009, Pages: 1047–1055, Marina Braun, Willi Cawello, Jens-Otto Andreas, Dipl Math, Hilmar Boekens and Rolf Horstmann

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009338481

  12. Levodopa

    Movement Disorders

    Volume 17, Issue S4, July/August 2002, Pages: S23–S37,

    Version of Record online : 29 JUL 2002, DOI: 10.1002/mds.5558

  13. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  14. You have free access to this content
    Abstracts

    Movement Disorders

    Volume 32, Issue S2, June 2017, Pages: S1–S627,

    Version of Record online : 2 JUN 2017, DOI: 10.1002/mds.27087

  15. You have free access to this content
    Pharmacokinetics of levodopa/benserazide versus levodopa/carbidopa in healthy subjects and patients with Parkinson's disease

    Neurology and Clinical Neuroscience

    Volume 3, Issue 2, March 2015, Pages: 68–73, Hirotaka Iwaki, Noriko Nishikawa, Masahiro Nagai, Tomoaki Tsujii, Hayato Yabe, Madoka Kubo, Ichiro Ieiri and Masahiro Nomoto

    Version of Record online : 8 DEC 2014, DOI: 10.1111/ncn3.152

  16. You have free access to this content
    Abstracts of The Movement Disorder Society's Eleventh International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 22, Issue S16, 2007, Pages: S1–S325,

    Version of Record online : 24 APR 2007, DOI: 10.1002/mds.21535

  17. 2nd World Parkinson Congress Abstracts

    Movement Disorders

    Volume 25, Issue S3, 15 September 2010, Pages: S569–S717,

    Version of Record online : 9 SEP 2010, DOI: 10.1002/mds.23386

    Corrected by:

    Erratum: Erratum

    Vol. 25, Issue 15, 2694, Version of Record online: 10 NOV 2010

  18. Should levodopa dose be reduced when switched to stalevo?

    European Journal of Neurology

    Volume 15, Issue 3, March 2008, Pages: 257–261, G. Linazasoro, J. Kulisevsky, B. Hernández and on behalf of the Spanish Stalevo Study Group

    Version of Record online : 22 JAN 2008, DOI: 10.1111/j.1468-1331.2007.02047.x

  19. You have full text access to this OnlineOpen article
    Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets

    British Journal of Clinical Pharmacology

    Volume 78, Issue 1, July 2014, Pages: 94–105, Ahmed A. Othman and Sandeep Dutta

    Version of Record online : 20 JUN 2014, DOI: 10.1111/bcp.12324

  20. The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: The mechanism of action in the treatment of parkinsonism

    Annals of Neurology

    Volume 18, Issue 5, November 1985, Pages: 537–543, Dr. John G. Nutt, William R. Woodward and John L. Anderson

    Version of Record online : 7 OCT 2004, DOI: 10.1002/ana.410180505